Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia

Cancer Letters

Volumn 279, Issue 1, 2009, Pages 108-117

  Lin, Sensen ^a   Sun, Li ^a   Hu, Jialiang ^a   Wan, Shuying ^a   Zhao, Renping ^a   Yuan, Shengtao ^a   Zhang, Luyong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cancer cell migration; Chemokine receptor; CXCR6; Hypoxia

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CELL HYPOXIA; CELL MIGRATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; UMBILICAL VEIN;

ADULT; AGED; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CHEMOTAXIS; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; RECEPTORS, CHEMOKINE; RECEPTORS, VIRUS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 67349279252     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.01.029     Document Type: Article

References (34)

1. Gupta S.K., Lysko P.G., Pillarisetti K., Ohlstein E., and Stadel J.M. Chemokine receptors in human endothelial cells: Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J. Biol. Chem. 273 (1998) 4282-4287
2. Opdenakker G., and Van Damme J. The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines. Int. J. Dev. Biol. 48 (2004) 519-527
3. Vandercappellen J., Van Damme J., and Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 267 (2008) 226-244
4. Huang J., Chen K., Gong W., Dunlop N.M., and Wang J.M. G-protein coupled chemoattractant receptors and cancer. Front. Biosci. 13 (2008) 3352-3363
5. Wang B., Hendricks D.T., Wamunyokoli F., and Parker M.I. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res. 66 6 (2006) 3071-3077
6. Brat D.J., Bellail A.C., and Van Meir E.G. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro. Oncol. 7 (2005) 122-133
7. Kucia M., Jankowski K., Reca R., Wysoczynski M., Bandura L., Allendorf D.J., Zhang J., Ratajczak J., and Ratajczak M.Z. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J. Mol. Histol. 35 (2004) 233-245
8. Howard O.M., and Galligan C.L. An expanding appreciation of the role chemokine receptors play in cancer progression. Curr. Pharm. Des. 10 (2004) 2377-2389
9. Sun Y.X., Wang J., Shelburne C.E., Lopatin D.E., Chinnaiyan A.M., Rubin M.A., Pienta K.J., and Taichman R.S. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J. Cell Biochem. 89 (2003) 462-473
10. Liang Z., Wu T., Lou H., Yu X., Taichman R.S., Lau S.K., Nie S., Umbreit J., and Shim H. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res. 64 (2004) 4302-4308
11. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E., and Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
12. Liang Z., Yoon Y., Votaw J., Goodman M.M., Williams L., and Shim H. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 65 3 (2005) 967-971
13. Shields J.D., Emmett M.S., Dunn D.B., Joory K.D., Sage L.M., Rigby H., Mortimer P.S., Orlando A., Levick J.R., and Bates D.O. Chemokine-mediated migration of melanoma cells towards lymphatics - a mechanism contributing to metastasis. Oncogene 26 21 (2006) 2997-3005
14. Alkhatib G., Liao F., Berger E.A., Farber J.M., and Peden K.W. A new SIV co-receptor, STRL33. Nature 388 (1997) 238
15. Deng H.K., Unutmaz D., KewalRamani V.N., and Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388 (1997) 296-300
16. Unutmaz D., Xiang W., Sunshine M.J., Campbell J., Butcher E., and Littman D.R. The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J. Immunol. 165 (2000) 3284-3292
17. Ou D.L., Chen C.L., Lin S.B., Hsu C.H., and Lin L.I. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. J. Pathol. 210 (2006) 363-373
18. Seidl H., Richtig E., Tilz H., Stefan M., Schmidbauer U., Asslaber M., Zatloukal K., Herlyn M., and Schaider H. Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma. Hum. Pathol. 38 5 (2007) 768-780
19. Sordi V., Malosio M.L., Marchesi F., Mercalli A., Melzi R., Giordano T., Belmonte N., Ferrari G., Leone B.E., Bertuzzi F., Zerbini G., Allavena P., Bonifacio E., and Piemonti L. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106 2 (2005) 419-427
20. Eble J.N., Sauter G., Epstein J.I., and Sesterhenn I.A. WHO Classification of Tumors: Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs (2004), IARC Press, Lyon
21. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S., Bussolino F., Poli V., Ciliberto G., and Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6 (1997) 315-325
22. Chi J.T., Wang Z., Nuyten D.S., Rodriguez E.H., Schaner M.E., Salim A., Wang Y., Kristensen G.B., Helland A., Børresen-Dale A.L., Giaccia A., Longaker M.T., Hastie T., Yang G.P., van de Vijver M.J., and Brown P.O. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med. 3 3 (2006) e47
23. Maranchie J.K., and Zhan Y. Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. Cancer Res. 65 20 (2005) 9190-9193
24. Petering H., Kluthe C., Dulkys Y., Kiehl P., Ponath P.D., Kapp A., and Elsner J. Characterization of the CC chemokine receptor 3 on human keratinocytes. J. Invest. Dermatol. 116 (2001) 549-555
25. Haseneen N.A., Vaday G.G., Zucker S., and Foda H.D. Mechanical stretch induces MMP-2 release and activation in lung endothelium: role of EMMPRIN. Am. J. Physiol. Lung Cell Mol. 284 3 (2003) L541-L547
26. Rapisarda A., Uranchimeg B., Scudiero D.A., Selby M., Sausville E.A., Shoemaker R.H., and Melillo G. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62 15 (2002) 4316-4324
27. Rapisarda A., Uranchimeg B., Sordet O., Pommier Y., Shoemaker R.H., and Melillo G. Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications. Cancer Res. 64 4 (2004) 1475-1482
28. Lu Y., Wang J., Xu Y., Koch A.E., Cai Z., Chen X., Galson D.L., Taichman R.S., and Zhang J. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Mol. Cancer Res. 6 4 (2008) 546-554
29. Hu W., Zhen X., Xiong B., Wang B., Zhang W., and Zhou W. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells. Cancer Sci. 99 7 (2008) 1362-1369
30. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8 4 suppl. (2002) S62-S67
31. Matsumura S., Wang B., Kawashima N., Braunstein S., Badura M., Cameron T.O., Babb J.S., Schneider R.J., Formenti S.C., Dustin M.L., and Demaria S. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J. Immunol. 181 5 (2008) 3099-3107
32. Hojo S., Koizumi K., Tsuneyama K., Arita Y., Cui Z., Shinohara K., Minami T., Hashimoto I., Nakayama T., Sakurai H., Takano Y., Yoshie O., Tsukada K., and Saiki I. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res. 67 10 (2007) 4725-4731
33. Biswas S.K., Gangi L., Paul S., Schioppa T., Saccani A., Sironi M., Bottazzi B., Doni A., Vincenzo B., Pasqualini F., Vago L., Nebuloni M., Mantovani A., and Sica A. A distinct and unique transcriptional programme expressed by tumor-associated macrophages: defective NF-{kappa}B and enhanced IRF-3/STAT1 activation. Blood 107 (2006) 2112-2122
34. Nakayama T., Hieshima K., Izawa D., Tatsumi Y., Kanamaru A., and Yoshie O. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J. Immunol. 170 3 (2003) 1136-1140